DR. ALEX GIAQUINTO, PHD
Corporate Board Profile
Tech Score:
0
/100
← Back to All Directors
CANNAPHARMARX, INC.
Filing Date
Source Excerpt
2015-07-17
Dr. Giaquinto has extensive drug development and commercialization experience.
Data sourced from SEC filings. Last updated: 2026-02-03